Literature DB >> 22361273

Anti-mycobacterial activities of some cationic and anionic calix[4]arene derivatives.

Maxime Mourer1, Hugues Massimba Dibama, Patricia Constant, Mamadou Daffé, Jean-Bernard Regnouf-de-Vains.   

Abstract

Various polycharged calix[4]arenes were assayed as anti-mycobacterial agents against Mycobacterium tuberculosis, H(37)Rv strain. The sulfonate, carboxylate and phosphonate anionic species displayed no activity. Cationic derivatives integrating four aminoethyl groups at the upper rim and two 6,6'-dimethyl-2,2'-bipyridyl- or 4,4'-dimethyl-2,2'-bithiazolyl subunits at the lower rim were also found inactive against M. tuberculosis, while the unsubstituded and the 5,5'-dimethyl-2,2'-bipyridyl-analogues exhibited MIC values of 3.2 and 0.8μM respectively. Introduction of guanidinoethyl groups at the upper rim resulted, except for the 6,6'-dimethyl-2,2'-bipyridyl-derivative, in high anti-mycobacterial activities for the unsubstituted, the 5,5'-dimethyl-2,2'-bipyridyl- and the 4,4'-dimethyl-2,2'-bithiazolyl analogues, with MIC values of 0.8, 0.8 and 1.6μM, respectively, similar to those of current commercial anti-tuberculosis agents. The five more active substances were also evaluated against the isoniazid-resistant strain MYC5165, resulting in highly interesting micromolar or sub-micromolar MIC and IC(50), ca. 4-125 times more active than isoniazid. These preliminary results are attractive for the development of new anti-TB agents. Copyright Â
© 2012. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22361273     DOI: 10.1016/j.bmc.2012.01.041

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

Review 1.  Calix[4]API-s: fully functionalized calix[4]arene-based facial active pharmaceutical ingredients.

Authors:  Fazel Nasuhi Pur
Journal:  Mol Divers       Date:  2020-01-31       Impact factor: 2.943

Review 2.  Antimicrobial Activity of Calixarenes and Related Macrocycles.

Authors:  Dmitriy N Shurpik; Pavel L Padnya; Ivan I Stoikov; Peter J Cragg
Journal:  Molecules       Date:  2020-11-05       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.